Vein Thrombosis Clinical Trials

56 recruitingLast updated: July 25, 2026

There are 56 actively recruiting vein thrombosis clinical trials across 24 countries. Studies span Not Applicable, Phase 4, Phase 2, Phase 3, Early Phase 1. Top locations include Shanghai, Shanghai Municipality, China, Grenoble, France, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


Vein Thrombosis Trials at a Glance

56 actively recruiting trials for vein thrombosis are listed on ClinicalTrialsFinder across 6 cities in 24 countries. The largest study group is Not Applicable with 15 trials, with the heaviest enrollment activity in Shanghai, Grenoble, and Beijing. Lead sponsors running vein thrombosis studies include RenJi Hospital, Mayo Clinic, and Leiden University Medical Center.

Browse vein thrombosis trials by phase

Treatments under study

About Vein Thrombosis Clinical Trials

Looking for clinical trials for Vein Thrombosis? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Vein Thrombosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Vein Thrombosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 56 trials

Recruiting
Not Applicable

PROfunda Femoris Vein Thrombosis Evaluation and Clearance to Improve Outcomes of Endovascular Treatment for Acute Iliofemoral Deep Vein Thrombosis

Deep Vein Thrombosis
RenJi Hospital140 enrolled1 locationNCT07622199
Recruiting

Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

Peripheral Arterial DiseaseDVTAcute Limb Ischemia+8 more
Medtronic Endovascular50 enrolled3 locationsNCT07335341
Recruiting

Impedance Plethysmography Based Deep Vein Thrombosis Monitoring During Catheter-directed Thrombolysis

Deep Vein Thrombosis (DVT)
Tampere University40 enrolled2 locationsNCT07665320
Recruiting
Phase 3

RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing

Venous ThromboembolismPulmonary EmbolismDeep Vein Thrombosis+3 more
University Hospital, Angers1,424 enrolled37 locationsNCT06195540
Recruiting

Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking

Deep Vein Thrombosis (DVT)Venous EmbolismThrombus in the Peripheral Venous Vasculature+1 more
Argon Medical Devices185 enrolled4 locationsNCT07102160
Recruiting

Cerebral Venous Thrombosis Cohort Study in China Mainland

Cerebral Venous Sinus ThrombosisDeep Cerebral Vein ThrombosisCortical Vein Thrombosis
Capital Medical University3,000 enrolled1 locationNCT03919305
Recruiting

Comparison Of Different Mechanical Thrombectomy Devices in Endovascular Treatment of Acute Iliofemoral Venous Thrombosis

Deep Vein Thrombosis
RenJi Hospital180 enrolled1 locationNCT07622212
Recruiting

ClotTriever® Thrombectomy System Use-Result Survey in Japan

Deep Vein Thrombosis
Inari Medical100 enrolled13 locationsNCT06871683
Recruiting

Freiburg TIPS Registry

Liver CirrhosisPortal Vein ThrombosisPortal Hypertension+3 more
University Hospital Freiburg2,000 enrolled1 locationNCT05782556
Recruiting

Registry of Patients Prescribed Anticoagulation

Acute Pulmonary EmbolismAcute Deep Vein Thrombosis
Mayo Clinic10,000 enrolled1 locationNCT03504007
Recruiting

Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study

Venous ThromboembolismPulmonary EmbolismDeep Vein Thrombosis
Cook Research Incorporated82 enrolled7 locationsNCT05881798
Recruiting
Early Phase 1

Apixaban in Thrombocytopenia

ThrombocytopeniaDeep Vein ThrombosisPulmonary Embolism and Thrombosis+1 more
Rushad Patell30 enrolled1 locationNCT06886516
Recruiting

Prospective Evaluation of the Treatment of Cancer Associated Superficial Venous

CancerSuperficial Vein ThrombosisVenous thrombosis
Centre Hospitalier Universitaire, Amiens1,576 enrolled1 locationNCT07210671
Recruiting
Not Applicable

The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study

Venous UlcerVenous StenosisVenous Occlusion+7 more
W.L.Gore & Associates165 enrolled27 locationsNCT05489588
Recruiting
Phase 4

Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis

CirrhosisAscitesPortal Vein Thrombosis+3 more
Asian Institute Of Medical Sciences220 enrolled1 locationNCT07521332
Recruiting
Not Applicable

Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD

CirrhosisPortal Vein ThrombosisHypertension, Portal+1 more
Northern Jiangsu People's Hospital20 enrolled1 locationNCT07461532
Recruiting
Not Applicable

Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS

CirrhosisPortal Vein ThrombosisHypertension, Portal+1 more
Northern Jiangsu People's Hospital20 enrolled1 locationNCT07461545
Recruiting
Not Applicable

Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage

Venous ThromboembolismPulmonary EmbolismDeep Vein Thrombosis+1 more
Pirogov Russian National Research Medical University200 enrolled1 locationNCT06753786
Recruiting

Clinical Application of Wearable Ultrasound Sensors

DVT - Deep Vein ThrombosisPOCUS
Chinese PLA General Hospital300 enrolled1 locationNCT07009873
Recruiting

Indicators Affecting PVT Recanalization

CirrhosisPortal Hypertension Related to CirrhosisPortal Vein Thrombosis+1 more
Shanghai Zhongshan Hospital1,500 enrolled1 locationNCT07473375